DTaP combined vaccine (Changchun BCHT Biotechnology)

N/A

Report date: 2026/04/20 20:01:59

Base Information

Drug NameDTaP combined vaccine (Changchun BCHT Biotechnology)
Drug Alias NameB-1004
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Toxoid vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaWhooping Cough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangchun Bcht Biotechnology Co
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Bcht Biotechnology Co
Inactive CompaniesN/A
Active IndicationsTetanusDiphtheriaWhooping Cough
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A